A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

UC San Diego researchers found a blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear, according to a paper published Tuesday.

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...

Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.

A blood test is a medical procedure where a sample of a person's blood is taken (called a blood draw) and sent to a lab for analysis. Knowing the results of blood tests helps a physician better ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.